Dierks Jeffrey's Form 4 filing
Harmony Biosciences Holdings, Inc. (HRMY) · filed Mar 11, 2024
- Accession no.
- 0001415889-24-007527
- Filed
- Mar 11, 2024
- Trade date
- Mar 8, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market sales total $6.21K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dierks JeffreyCIK 0001821102 | Officer (CHIEF COMMERCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 8, 2024 | Common Stock | MOption exerciseAcquired | +194 | $8.22 | +$1,594.68 | 194 | Direct | |
| Mar 8, 2024 | Common Stock | SSaleDisposed | −194 | $32.00 | −$6,208 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 8, 2024 | Common Stock | MOption exerciseDisposed | −100 | $0.00 | $0 | 2,335 | Direct | |
| Mar 8, 2024 | Common Stock | MOption exerciseDisposed | −94 | $0.00 | $0 | 14,513 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.